Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group Study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples